The bacterial protein AAzurin enhances sensitivity of oral squamous carcinoma cells to anticancer drugs

Yonsei Medical Journal

Volumn 52, Issue 5, 2011, Pages 773-778

  Choi, Jeong Hae ^a   Lee, Moo Hyung ^a   Cho, Yun Jung ^a   Park, Bong Soo ^a   Kim, Shin ^a   Kim, Gyoo Cheon ^a  

^a Pusan National University Hospital   (South Korea)

Author keywords

5 fluorouracil; Azurin; Etoposide; Oral squamous carcinoma; Osteosarcoma

Indexed keywords

AZURIN; CYCLIN B1; DNA; ETOPOSIDE; FLUOROURACIL; PROTEIN P53; ANTINEOPLASTIC AGENT; CCNB1 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA STRAND BREAKAGE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MOUTH CARCINOMA; MOUTH SQUAMOUS CELL CARCINOMA; PHENOTYPE; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; DRUG EFFECT; DRUG POTENTIATION; GENETICS; METABOLISM; MOUTH TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; AZURIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CYCLIN B1; DRUG SYNERGISM; ETOPOSIDE; FLUOROURACIL; HUMANS; MOUTH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79960980733     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2011.52.5.773     Document Type: Article

References (12)

1. Hooper SJ, Wilson MJ, Crean SJ. Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck 2009;31:1228-39.
2. Chen XX, Lai MD, Zhang YL, Huang Q. Less cytotoxicity to combination therapy of 5-fluorouracil and cisplatin than 5-fluorouracil alone in human colon cancer cell lines. World J Gastroenterol 2002;8:841-6.
3. Yamada T, Fialho AM, Punj V, Bratescu L, Gupta TK, Chakrabarty AM. Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity. Cell Microbiol 2005;7: 1418-31.
4. Yamada T, Goto M, Punj V, Zaborina O, Chen ML, Kimbara K, et al. Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer. Proc Natl Acad Sci U S A 2002;99: 14098-103.
5. Punj V, Bhattacharyya S, Saint-Dic D, Vasu C, Cunningham EA, Graves J, et al. Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer. Oncogene 2004;23: 2367-78.
6. Yamada T, Goto M, Punj V, Zaborina O, Kimbara K, Das Gupta TK, et al. The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53. Infect Immun 2002;70:7054-62.
7. Yang DS, Miao XD, Ye ZM, Feng J, Xu RZ, Huang X, et al. Bacterial redox protein azurin induce apoptosis in human osteosarcoma U2OS cells. Pharmacol Res 2005;52:413-21.
8. Borgne A, Versteege I, Mahé M, Studeny A, Léonce S, Naime I, et al. Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment. Oncogene 2006;25:7361-72.
9. Porter LA, Singh G, Lee JM. Abundance of cyclin B1 regulates gamma-radiation-induced apoptosis. Blood 2000;95:2645-50.
10. Porter LA, Cukier IH, Lee JM. Nuclear localization of cyclin B1 regulates DNA damage-induced apoptosis. Blood 2003;101:1928-33.
11. Yoshiba S, Ito D, Nagumo T, Shirota T, Hatori M, Shintani S. Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G(1) phase cell cycle arrest. Oral Oncol 2009;45:109-15.
12. Gomez LA, de Las Pozas A, Reiner T, Burnstein K, Perez-Stable C. Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy. Mol Cancer Ther 2007;6:1534-43.